Inventor
Chudi Ndubaku
Inventor
San Francisco, CA, US
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes25%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
C07HSugars3%
C07KPeptides3%
C12NMicroorganisms or enzymes1%
PatentTitleYear
11,098,077Locked nucleic acid cyclic dinucleotide compounds and uses thereof202110,988,478Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators202110,975,114Bis 2'-5'-RR-(3'F-A)(3'F-A) cyclic dinucleotide compound and uses thereof202110,906,918Process for the preparation of tricyclic PI3K inhibitor compounds and methods for using the same for the treatment of cancer202110,906,930Compositions and methods for activating "stimulator of interferon gene"-dependent signalling202110,738,056Pyrazolopyrimidinone compounds and uses thereof20209,670,228'Benzoxazepin PI3K inhibitor compounds and methods of use'20179,592,235'Aminoquinazoline and pyridopyrimidine derivatives'20179,586,956'Isoquinoline and naphthyridine derivatives'20179,573,899'USP7 inhibitor compounds and methods of use'20179,546,182'Tricyclic PI3K inhibitor compounds and methods of use'20179,546,178'Benzoxazepin PI3K inhibitor compounds and methods of use'20179,382,241'Aminoquinazoline and pyridopyrimidine derivatives'20169,198,918'Benzoxazepin PI3K inhibitor compounds and methods of use'20159,175,009'Benzoxepin PI3K inhibitor compounds and methods of use'20159,067,928'Compounds and methods of use'20158,952,043'Benzoxepin PI3K inhibitor compounds and methods of use'20158,907,092'Inhibitors of IAP'20148,883,799'Tricyclic PI3K inhibitor compounds and methods of use'20148,835,393'Inhibitors of IAP'20148,785,626'Benzoxazepin PI3K inhibitor compounds and methods of use'20148,673,952'Benzoxepin PI3K inhibitor compounds and methods of use'20148,586,574'Benzoxazepin PI3K inhibitor compounds and methods of use'20138,518,970'Compounds and methods of use'20138,343,955'Benzoxazepin PI3K inhibitor compounds and methods of use'20138,263,633'Benzoxepin PI3K inhibitor compounds and methods of use'20128,242,104'Benzoxazepin P13K inhibitor compounds and methods of use'20128,232,273'Heterocyclic compounds and methods of use'20128,114,893'Compounds and methods of use'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012–2021Patents assigned to GENENTECH INC (22)· patent assignee history
2012–2014Patents assigned to NDUBAKU CHUDI (10)· patent assignee history
2012–2014Patents assigned to DUDLEY DANETTE (5)· patent assignee history
2012–2014Patents assigned to FLYGARE JOHN A (5)· patent assignee history
2012–2014Patents assigned to HEFFRON TIMOTHY (5)· patent assignee history
2012–2017Based in San Francisco, CA, US· patent location history
2012–2021Based in South San Francisco, CA, US· patent location history
2015Based in Thomastown, AU· patent location history
2020–2021Based in Oakland, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENENTECH INC | 22 | 2012–2021 |
| NDUBAKU CHUDIself | 10 | 2012–2014 |
| DUDLEY DANETTE | 5 | 2012–2014 |
| FLYGARE JOHN A | 5 | 2012–2014 |
| HEFFRON TIMOTHY | 5 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 16 | 2012–2017 |
| South San Francisco, California, US | 7 | 2012–2021 |
| Oakland, California, US | 5 | 2020–2021 |
| Thomastown, AU | 1 | 2015 |